Tuesday, December 9, 2025

'Energy Drinks Blamed for Man's Severe High Blood Pressure, Stroke'

›
  A case report detailed a man's stroke and severe hypertension that was uncontrolled despite blood pressure medication. Further questio...

'Absolutely Ignore Them': Med societies, health departments, insurers still support HBV birth vax

›
  A CDC vaccine advisory panel's   decision   to stop recommending universal hepatitis B vaccination for newborns has sparked a split be...

Pfizer in pact with China’s Fosun Pharma for oral GLP-1 drugs

›
  Chinese drugmaker Fosun Pharma ( SFOSF ) on Tuesday announced a global licensing agreement with Pfizer ( PFE ) to hand the U.S. pharma gia...

Vor Bio spikes as J.P. Morgan starts at Overweight on lead asset

›
  Vor Biopharma ( VOR )   rose ~17%   on Tuesday after J.P. Morgan initiated its coverage with an Overweight recommendation and a Dec. 2026 ...

Citius Oncology added to the Russell Microcap Index

›
  Citius Oncology ( CTOR ) has been added to the Russell Microcap Index. Inclusion becomes effective at the market open on December 22, 2025...

Sarepta a new outperform at Wedbush as selloff overdone

›
  Wedbush has initiated Sarepta Therapeutics ( SRPT ) at outperform saying that a selloff that began earlier this year following the   death...

Ligand Pharma sets 2026 outlook as Citi starts at Buy on valuation

›
  As  Ligand Pharma ( LGND ) held its Investor Day in New York City on Tuesday, Citi initiated its coverage with a Buy recommendation and a ...